Acutrol 400 Tablet

By Acutrol

Rx

15 Tablet in a Strip

Composition icon

Composition

Sevelamer(400mg)

Manufacturer - Intas Pharmaceuticals Ltd icon

Manufacturer - Intas Pharmaceuticals Ltd

Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after icon

Expires on or after

July, 2025

About Acutrol 400 Tablet

Acutrol 400 Tablet, also known as ACUTROL 400MG TABLET, is a medication classified as a phosphate binder. This medicine is specifically designed to address elevated levels of phosphate in the blood, a condition typically observed in patients with severe kidney disease undergoing dialysis treatment. By inhibiting the absorption of phosphate from the intestine, Acutrol 400 Tablet effectively reduces the levels of phosphate in the blood, helping to manage hyperphosphatemia in adult patients on dialysis or suffering from chronic kidney disease.

The primary active ingredient in Acutrol 400 Tablet is sevelamer, which operates by binding phosphate in the gastrointestinal tract, thereby reducing its absorption and effectively controlling the excess phosphate levels in the blood. Additionally, this medication plays a crucial role in preventing the dangerous accumulation of phosphate in the body, promoting bone health, and decreasing the risk of cardiovascular issues such as heart disease and strokes.

When using Acutrol 400 Tablet, it is essential to adhere to the prescribed dosage and schedule recommended by your healthcare provider. Taking this medication consistently at the same time each day with food is crucial to derive its maximum benefits. However, like any medication, Acutrol 400 Tablet may cause certain side effects such as nausea, vomiting, abdominal pain, constipation, and diarrhea. In some cases, individuals may experience decreased levels of calcium, folic acid, as well as vitamins A, D, E, and K in their blood, necessitating the supplementation of these nutrients as directed by a medical professional.

Prior to initiating treatment with Acutrol 400 Tablet, it is important to disclose any known allergies to its ingredients and discuss any pre-existing conditions such as low blood phosphorus levels or bowel obstruction with your doctor. Patients with specific issues related to swallowing, motility in the stomach and bowel, a history of major stomach or bowel surgery, or inflammatory bowel disease should approach the use of this medication with caution. Additionally, pregnant or breastfeeding individuals should seek guidance from their healthcare provider before commencing Acutrol 400 Tablet to ensure its safety and efficacy in their respective situations. It is worth noting that this medication is not intended for use in children and adolescents under the age of 18.

In summary, Acutrol 400 Tablet serves as a valuable treatment option for managing high phosphate levels in patients with chronic kidney disease undergoing dialysis. By following the prescribed regimen and addressing any potential side effects or contraindications with medical supervision, individuals can effectively leverage the benefits of this medication in promoting their overall health and well-being.


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

336.5

Inclusive of all taxes

Content verified by

chevron-right

Dr. Gowri Kulkarni

MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)

Last update on 01-Oct-2024